INCR
Price
$1.70
Change
-$0.05 (-2.86%)
Updated
Jan 17 closing price
Capitalization
123.5M
79 days until earnings call
PHCUF
Price
$5.17
Change
+$0.17 (+3.40%)
Updated
Jan 7 closing price
Capitalization
128.95M
Ad is loading...

INCR vs PHCUF

Header iconINCR vs PHCUF Comparison
Open Charts INCR vs PHCUFBanner chart's image
Intercure
Price$1.70
Change-$0.05 (-2.86%)
Volume$5.37K
Capitalization123.5M
Photocure ASA
Price$5.17
Change+$0.17 (+3.40%)
Volume$400
Capitalization128.95M
INCR vs PHCUF Comparison Chart
Loading...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INCR vs. PHCUF commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INCR is a Hold and PHCUF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (INCR: $1.70 vs. PHCUF: $5.17)
Brand notoriety: INCR and PHCUF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: INCR: 12% vs. PHCUF: 48%
Market capitalization -- INCR: $123.5M vs. PHCUF: $128.95M
INCR [@Pharmaceuticals: Other] is valued at $123.5M. PHCUF’s [@Pharmaceuticals: Other] market capitalization is $128.95M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INCR’s FA Score shows that 1 FA rating(s) are green whilePHCUF’s FA Score has 0 green FA rating(s).

  • INCR’s FA Score: 1 green, 4 red.
  • PHCUF’s FA Score: 0 green, 5 red.
According to our system of comparison, INCR is a better buy in the long-term than PHCUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INCR’s TA Score shows that 5 TA indicator(s) are bullish.

  • INCR’s TA Score: 5 bullish, 4 bearish.

Price Growth

INCR (@Pharmaceuticals: Other) experienced а +1.49% price change this week, while PHCUF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.23%. For the same industry, the average monthly price growth was +2.88%, and the average quarterly price growth was -9.56%.

Reported Earning Dates

INCR is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHCUF($129M) and INCR($124M) have the same market capitalization . PHCUF has higher P/E ratio than INCR: PHCUF (500.00) vs INCR (22.52). INCR YTD gains are higher at: 6.918 vs. PHCUF (-7.627). INCR has higher annual earnings (EBITDA): 25.8M vs. PHCUF (-2.74M). PHCUF has more cash in the bank: 246M vs. INCR (103M). PHCUF has less debt than INCR: PHCUF (6.25M) vs INCR (163M). PHCUF (418M) and INCR (415M) have equivalent revenues.
INCRPHCUFINCR / PHCUF
Capitalization124M129M96%
EBITDA25.8M-2.74M-940%
Gain YTD6.918-7.627-91%
P/E Ratio22.52500.005%
Revenue415M418M99%
Total Cash103M246M42%
Total Debt163M6.25M2,608%
FUNDAMENTALS RATINGS
INCR vs PHCUF: Fundamental Ratings
INCR
PHCUF
OUTLOOK RATING
1..100
3198
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8587
PRICE GROWTH RATING
1..100
4544
P/E GROWTH RATING
1..100
4100
SEASONALITY SCORE
1..100
9550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INCR's Valuation (69) in the Servicestothe Health Industry industry is in the same range as PHCUF (90) in the null industry. This means that INCR’s stock grew similarly to PHCUF’s over the last 12 months.

INCR's Profit vs Risk Rating (100) in the Servicestothe Health Industry industry is in the same range as PHCUF (100) in the null industry. This means that INCR’s stock grew similarly to PHCUF’s over the last 12 months.

INCR's SMR Rating (85) in the Servicestothe Health Industry industry is in the same range as PHCUF (87) in the null industry. This means that INCR’s stock grew similarly to PHCUF’s over the last 12 months.

PHCUF's Price Growth Rating (44) in the null industry is in the same range as INCR (45) in the Servicestothe Health Industry industry. This means that PHCUF’s stock grew similarly to INCR’s over the last 12 months.

INCR's P/E Growth Rating (4) in the Servicestothe Health Industry industry is significantly better than the same rating for PHCUF (100) in the null industry. This means that INCR’s stock grew significantly faster than PHCUF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INCR
RSI
ODDS (%)
Bearish Trend 5 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
81%
Momentum
ODDS (%)
Bullish Trend 5 days ago
79%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
75%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Declines
ODDS (%)
Bearish Trend 20 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
87%
Aroon
ODDS (%)
Bullish Trend 5 days ago
83%
View a ticker or compare two or three
Ad is loading...
INCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X104462.0400004705.133000
+4.72%
Bitcoin cryptocurrency
TSLA426.5012.68
+3.06%
Tesla
SPY597.585.94
+1.00%
SPDR® S&P 500® ETF Trust
AAPL229.981.72
+0.75%
Apple
GME27.51-0.21
-0.76%
GameStop Corp

INCR and

Correlation & Price change

A.I.dvisor tells us that INCR and KMDA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
-2.60%
KMDA - INCR
31%
Poorly correlated
+0.99%
TLRY - INCR
27%
Poorly correlated
+1.69%
PHCUF - INCR
26%
Poorly correlated
N/A
OGI - INCR
26%
Poorly correlated
-1.27%
CGC - INCR
24%
Poorly correlated
-3.11%
More

PHCUF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHCUF has been loosely correlated with HLTRF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PHCUF jumps, then HLTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHCUF
1D Price
Change %
PHCUF100%
N/A
HLTRF - PHCUF
38%
Loosely correlated
N/A
INCR - PHCUF
26%
Poorly correlated
-2.60%
ELAN - PHCUF
24%
Poorly correlated
+0.08%
MKKGY - PHCUF
22%
Poorly correlated
-1.22%
CRYM - PHCUF
20%
Poorly correlated
N/A
More